Previous
Next

Country/Region

October 24, 2014

Following a high level meeting on access and funding for Ebola vaccines convened yesterday by World Health Organization (WHO), Médecins Sans Frontières/Doctors Without Borders (MSF) has urged that plans to get forthcoming Ebola vaccines and treatments to frontline workers must be rapidly implemented. Significant investment and incentives are needed now to accelerate these steps.

July 29, 2014

Médecins Sans Frontières/Doctors Without Borders (MSF) strongly condemns the July 28 attack on Gaza City’s Al Shifa hospital, where an MSF surgical team has been working. Al Shifa is the main referral hospital for the entire Gaza Strip.

July 21, 2014

Since the beginning of Operation Protective Edge in the Gaza Strip, the majority of the dead and wounded in Gaza are civilians, and medical workers are also coming under fire, the international medical humanitarian organization Médecins Sans Frontières/Doctors Without Borders (MSF) said today.

July 13, 2014

The intensity of bombings in the Israeli military operation “Protective Edge” makes it extremely dangerous for the population — and for Médecins Sans Frontières/Doctors Without Borders (MSF) medical teams  in Gaza to move around. As of today, hospitals in Gaza are managing to cope with the influx of wounded arriving.

The medical humanitarian organization Médecins Sans Frontières (MSF) is shocked by the judgment rendered by Switzerland's highest judicial body, the Federal Tribunal. Following four years of proceedings, and in spite of two previous rulings in favour of MSF, the Federal Tribunal partly ruled in favour of the Dutch state by ruling that the financial burden should be shared between the two parties. This decision sets a grave precedent for independent humanitarian action in zones of conflict.

The Executive Board of UNITAID, the international health financing agency, will meet Dec. 14-15 in Geneva to decide on the future direction of the Patent Pool for AIDS medicines. International medical humanitarian organization Médecins Sans Frontières (MSF) is concerned that a number of pharmaceutical companies are seeking to exclude developing countries categorized as ‘middle-income’ from benefiting from medicines made under licence from the Pool.  If these companies are successful, people living with HIV/AIDS will be made to pay the price.

In a decisive step to improve access to medicines in the developing world, the Executive Board of UNITAID, the international health financing agency, has given the green light for a patent pool for HIV/AIDS medicines to open for business. “Although these are early days, the patent pool could become a mechanism that systematically offers licenses to generic manufacturers, reducing prices and facilitating the combination of drugs from different makers into fixed-dose or one pill combinations,” said Dr.